Humpath.com - Human pathology

Home > A. Molecular pathology > Targeted therapy > Therapeutical antibodies > ixekizumab

ixekizumab

Tuesday 10 May 2016

WP

Ixekizumab binds to interleukin 17 and blocks its action. This mechanism is similar to that of another anti-psoriasis antibody, brodalumab, which also binds to the interleukin-17 receptor.

See also

- IL-17 inhibitors